399 related articles for article (PubMed ID: 21175974)
1. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.
Lee VW; Harris DC
Nephrology (Carlton); 2011 Jan; 16(1):30-8. PubMed ID: 21175974
[TBL] [Abstract][Full Text] [Related]
2. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
3. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis.
Rangan GK; Pippin JW; Couser WG
Kidney Int; 2004 Nov; 66(5):1838-48. PubMed ID: 15496154
[TBL] [Abstract][Full Text] [Related]
4. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.
Fries JW; Sandstrom DJ; Meyer TW; Rennke HG
Lab Invest; 1989 Feb; 60(2):205-18. PubMed ID: 2915515
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin attenuates the severity of murine adriamycin nephropathy.
Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
Am J Nephrol; 2009; 29(4):342-52. PubMed ID: 18948688
[TBL] [Abstract][Full Text] [Related]
6. Glomerulosclerosis 4 weeks after administration of adriamycin in a single dose.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):214-9. PubMed ID: 16145983
[TBL] [Abstract][Full Text] [Related]
7. A protective role for programmed death 1 in progression of murine adriamycin nephropathy.
Qin XH; Lee VW; Wang YP; Zheng GP; Wang Y; Alexander SI; Harris DC
Kidney Int; 2006 Oct; 70(7):1244-50. PubMed ID: 16900095
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis.
Shui HA; Ka SM; Yang SM; Lin YF; Lo YF; Chen A
Transl Res; 2007 Oct; 150(4):216-22. PubMed ID: 17900509
[TBL] [Abstract][Full Text] [Related]
9. Animal models of FSGS: lessons for pathogenesis and treatment.
Fogo AB
Semin Nephrol; 2003 Mar; 23(2):161-71. PubMed ID: 12704576
[TBL] [Abstract][Full Text] [Related]
10. The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy.
Lenderink AM; Liegel K; Ljubanović D; Coleman KE; Gilkeson GS; Holers VM; Thurman JM
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F555-64. PubMed ID: 17522263
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
[TBL] [Abstract][Full Text] [Related]
12. Focal segmental glomerulosclerosis: recent advances.
Pollak MR
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):138-42. PubMed ID: 18277145
[TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition for glomerulonephritis-induced glomerulosclerosis in rats is linked to chromosome 1.
Ijpelaar DH; Schulz A; Aben J; van der Wal A; Bruijn JA; Kreutz R; de Heer E
Physiol Genomics; 2008 Oct; 35(2):173-81. PubMed ID: 18682577
[TBL] [Abstract][Full Text] [Related]
14. Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy.
Asanuma K; Akiba-Takagi M; Kodama F; Asao R; Nagai Y; Lydia A; Fukuda H; Tanaka E; Shibata T; Takahara H; Hidaka T; Asanuma E; Kominami E; Ueno T; Tomino Y
Am J Nephrol; 2011; 33(6):537-49. PubMed ID: 21606645
[TBL] [Abstract][Full Text] [Related]
15. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
16. Role of CD8(+) cells in the progression of murine adriamycin nephropathy.
Wang Y; Wang YP; Tay YC; Harris DC
Kidney Int; 2001 Mar; 59(3):941-9. PubMed ID: 11231349
[TBL] [Abstract][Full Text] [Related]
17. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
18. Glomerular morphometry of adriamycin-induced focal and segmental glomerulosclerosis in the rat.
Güezmes A; Fernández F; Garijo F; Val-Bernal F
Am J Nephrol; 1992; 12(6):437-41. PubMed ID: 1292343
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury.
Zheng G; Wang Y; Xiang SH; Tay YC; Wu H; Watson D; Coombes J; Rangan GK; Alexander SI; Harris DC
J Am Soc Nephrol; 2006 Feb; 17(2):465-74. PubMed ID: 16396966
[TBL] [Abstract][Full Text] [Related]
20. Quantitative histological analysis of SM22α (transgelin) in an adriamycin-induced focal segmental glomerulosclerosis model.
Wang X; Sakatsume M; Sakamaki Y; Inomata S; Yamamoto T; Narita I
Nephron Exp Nephrol; 2012; 120(1):e1-11. PubMed ID: 22205114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
